Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT02900248||Recruiting||CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice||
||100000||All||18 Years and older (Adult, Senior)||NCT02900248||N1OR||N1||October 2, 2017||October 2021||October 2024||September 14, 2016||October 4, 2017||
|2||NCT00585195||Recruiting||A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer||
||600||All||18 Years and older (Adult, Senior)||NCT00585195||A8081001
|PROFILE 1001||April 19, 2006||January 31, 2018||November 11, 2019||January 3, 2008||January 17, 2018||